Parox Energy OÜ

Active Registry code 14737514 OÜ Pärnu linn Registered 5 Jun 2019
Compare

Parox Energy OÜ is a OÜ based in Pärnu linn, registry code 14737514, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q4 2025: 0 €
0.00.00.00.00.00.0Q4 2023 Company: 0 €Q4·23Q1 2024 Company: —Q2 2024 Company: —Q2·24Q3 2024 Company: 0 €Q4 2024 Company: —Q4·24Q1 2025 Company: 0 €Q2 2025 Company: —Q2·25Q3 2025 Company: —Q4 2025 Company: 0 €Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·260.00.00.00.00.00.0Q4 2024 Company: —Q1 2025 Company: 0 €Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: 0 €Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — — — —
Q2 2023 — — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2019 – 2025
Net profit, € thousand 2025: -256 € · −27.4% vs 2024 · industry median 0 € · above 28% of the industry
-150-100-500502019 Company: -17 544 € Industry median: 3 €20192020 Company: -120 528 € Industry median: 28 €20202021 Company: -97 610 € Industry median: 1 €20212022 Company: 8 224 € Industry median: 0 €20222023 Company: -3 990 € Industry median: 0 €20232024 Company: -201 € Industry median: 0 €20242025 Company: -256 € Industry median: 0 €2025-150-100-500502019 Company: -17 544 € Industry median: 3 €20192020 Company: -120 528 € Industry median: 28 €2021 Company: -97 610 € Industry median: 1 €20212022 Company: 8 224 € Industry median: 0 €2023 Company: -3 990 € Industry median: 0 €20232024 Company: -201 € Industry median: 0 €2025 Company: -256 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 5 625 € · −4.1% vs 2024
05 00010 00015 0002019 Company: 12 596 €20192020 Company: 6 936 €20202021 Company: 1 830 €20212022 Company: 12 163 €20222023 Company: 6 202 €20232024 Company: 5 866 €20242025 Company: 5 625 €202505 00010 00015 0002019 Company: 12 596 €20192020 Company: 6 936 €2021 Company: 1 830 €20212022 Company: 12 163 €2023 Company: 6 202 €20232024 Company: 5 866 €2025 Company: 5 625 €2025
Equity, € 2025: 5 595 € · −4.4% vs 2024
-10 000-5 00005 00010 0002019 Company: 9 956 €20192020 Company: -3 572 €20202021 Company: -6 182 €20212022 Company: 2 042 €20222023 Company: 6 052 €20232024 Company: 5 851 €20242025 Company: 5 595 €2025-10 000-5 00005 00010 0002019 Company: 9 956 €20192020 Company: -3 572 €2021 Company: -6 182 €20212022 Company: 2 042 €2023 Company: 6 052 €20232024 Company: 5 851 €2025 Company: 5 595 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — -256 — 5 625 5 595 0
2024 — -201 — 5 866 5 851 0
2023 — -3 990 — 6 202 6 052 0
2022 — 8 224 — 12 163 2 042 0
2021 — -97 610 0 1 830 -6 182 0
2020 — -120 528 — 6 936 -3 572 0
2019 — -17 544 0 12 596 9 956 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-4.6 %
Net profit / equity
Return on assets (ROA)
-4.6 %
Net profit / assets
Equity ratio
99.5 %
Equity / assets
Debt ratio
0.5 %
Liabilities / assets
Current ratio
187.50
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 17 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 11 Apr 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 14 May 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 7 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 28 Apr 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 5 May 2021 Company’s own e-Äriregister
2019 5 Jun 2019 – 31 Dec 2019 15 May 2020 Company’s own e-Äriregister

Board

  • Andres Reinaru
    Board member · since 10 Jun 2020
  • Nasdaq CSD SE
    Keeper of the share register · since 5 Jun 2019

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

  • KMG Investments OÜ
    Founder · 1 000 € · 24 May 2019
  • Osaühing PAIKRE
    Founder · 500 € · 24 May 2019
  • RoxTrade OÜ
    Founder · 1 000 € · 24 May 2019
shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50121133 / 9
5 Jun 2025
Amendment entry In force
5 Jun 2025
PDF
Ä 50121133 / M3
25 Apr 2025
Warning of compulsory dissolution: insufficient net assets 27 Oct 2025 Deficiencies eliminated
5 Jun 2025
PDF
Ä 50121133 / 8
24 May 2021
Amendment entry In force
24 May 2021
PDF
Ä 50121133 / 7
28 Jan 2021
Amendment entry In force
28 Jan 2021
PDF
Ä 50121133 / 6
26 Jun 2020
Amendment entry In force
26 Jun 2020
PDF
Ä 50121133 / M2
17 Jun 2020
Ruling to eliminate deficiencies 16 Aug 2020 Deficiencies eliminated
26 Jun 2020
PDF
Ä 50121133 / 5
17 Jun 2020
Amendment entry In force
17 Jun 2020
PDF
Ä 50121133 / 4
10 Jun 2020
Amendment entry In force
10 Jun 2020
PDF
Ä 50121133 / M1
14 May 2020
Ruling to eliminate deficiencies 13 Jun 2020 Deficiencies eliminated
10 Jun 2020
PDF
Ä 50121133 / 3
8 Nov 2019
Amendment entry In force
8 Nov 2019
PDF
Ä 50121133 / 2
16 Aug 2019
Amendment entry In force
16 Aug 2019
PDF
Ä 50121133
5 Jun 2019
First entry In force
5 Jun 2019
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data